21 CFR 520.1150

§ 520.1150 Imepitoin.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 520.1150, § 520.1150 Imepitoin, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87180
Permanent ID: ys:prov:87180@1
SHA-256: f7ee47ea0c2a38c3664208040af14de94f77c757c9a7873ecc1121226188c705

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. Each tablet contains 100 or 400 milligrams (mg) imepitoin. (b) Sponsor. See No. 000010 in § 510.600(c) of this chapter. (c) Conditions of use—(1) Amount. Administer orally twice daily, approximately 12 hours apart, at a dose of 13.6 mg per pound (30 mg/kg) of body weight. Initiate therapy starting 2 days prior to the day of the expected noise event and continuing through the noise event. (2) Indications for use. For the treatment of noise aversion in dogs. (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.